Novavax to Present at the 15th Annual Needham Healthcare Conference
April 06 2016 - 3:05PM
Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
Stanley C. Erck, President and Chief Executive Officer, will
present at the 15th Annual Needham Healthcare Conference.
Conference details are as follows:
Date: Wednesday, April 13, 2016Time: 8:40 a.m. U.S. Eastern
TimeLocation: Westin Grand Central hotel, New York CityLive
webcast: http://wsw.com/webcast/needham76/nvax
The webcast and a replay of the presentation
will also be accessible under the “Investors/Events” section of the
Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Its recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
ground-breaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the company's website, novavax.com.
Contact: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From May 2023 to May 2024